Dexlansoprazole

CAS 138530-94-6 14 FDA-DMF suppliersSmall Molecule

Overview

Dexlansoprazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201863).

API suppliers (11)

Suppliers of Dexlansoprazole backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • METROCHEM API PRIVATE LTD3 active DMF
  • Hetero Drugs LimitedIndia2 active DMF
  • MSN Laboratories Private LimitedIndia2 active DMF
  • Dipharma Francis SrlItaly1 active DMF
  • Dipharma Francis SrlItaly1 active DMF
  • MATRIX PHARMACORP PRIVATE LTD1 active DMF
  • Orchid Pharma LimitedIndia1 active DMF
  • MATRIX PHARMACORP PRIVATE LTD1 active DMF
  • Orchid Pharma LimitedIndia1 active DMF
  • Lupin LimitedIndia
  • WATERSTONE PHARMACEUTICALS (HUBEI) CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (10 approved US products), the latest listed US patent on Dexlansoprazole expires 5 Mar 2032. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole
Canonical SMILES
CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
InChIKey
MJIHNNLFOKEZEW-RUZDIDTESA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo